Summary To identify chromosomal loci involved in the development of proximal gastric adenocarcinoma, this study delineated the pattern of allelic imbalance in a series of 38 adenocarcinomas arising in the gastric cardia. A total of 137 microsatellite markers covering all autosomal arms, excluding acrocentric arms, were analysed. A mean of 35 out of a total of 39 chromosomal arms studied were informative for each patient. The tumour group demonstrated a high level of allelic imbalance, with an observed median fractional allelic imbalance of 0.47 for the 29 intestinal-type adenocarcinomas and 0.54 for the nine diffuse-type adenocarcinomas. Allelic imbalance was detected in >50% of informative cases in both histological subtypes on a number of chromosomal arms. In the intestinal subtype, these included, 3p (61%), 4q (71%), 5q (59%), 8p (60%), 9p (65%), 9q (83%), 12q (52%), 13q (52%), 17p (78%) and 18q (70%). A higher incidence of allelic imbalance was detected on chromosome 16q in tumours of the diffuse type relative to those of the intestinal type. A more detailed mapping on chromosomes 4q and 6q identified a number of cases with subchromosomal breakpoints. In conclusion, this analysis has indicated regions of the genome potentially involved in the development of proximal gastric carcinomas.
Gastric carcinoma demonstrates marked geographic variation in incidence and is morphologically heterogeneous. The World Health Organization classification divides tumours into tubular, papillary, signet-ring, mucinous and poorly differentiated types (Watanabe et al, 1990 ). An alternative classification includes the intestinal and diffuse types described by Lauren (1965) . In general, carcinomas of the gastric cardia have a poorer prognosis than those of the antrum and their relative incidence appears to be increasing in some countries (Sidoni et al, 1989; Blot et al, 1991) . These biological variations may reflect different genetic mechanisms underlying the development of proximal and distal gastric carcinoma.
Cancer develops as the result of an accumulation of genetic alterations that disrupt the normal processes of cell growth and differentiation (Hartwell, 1992) . Cells must undergo numerous genetic changes to generate a solid, metastatic tumour (Nowell, 1976) . Oncogene activation, combined with the loss or inactivation of tumour-suppressor genes, are key events in tumorigenesis. Tumour-suppressor gene inactivation usually results from a mutation within one copy of the gene and the subsequent loss of the remaining wild-type allele. Therefore, the identification of consistent areas of chromosomal deletion in tumour DNA may indicate regions harbouring such genes.
The development of colorectal cancer is characterized by an accumulation of genetic alterations including altered methylation patterns, ras mutation, and allelic loss at 5q, 17p and 18q
Received 28 February 1997 Revised 13 May 1997 Accepted 20 May 1997 Correspondence to: SEH Russell (Vogelstein et al, 1988) . Chromosomes 5q, 17p and 18q harbour the tumour-suppressor genes APC-MCC, p53, and DCC respectively (McBride et al, 1986; Fearon et al, 1990; Kinzler et al, 1991) and inactivation of these genes has been demonstrated in colorectal carcinoma (Baker et al, 1990; Fearon et al, 1990; Powell et al, 1992) . In contrast, the genetic events underlying the development of gastric cancer remain poorly characterized. Cytogenetic studies of gastric adenocarcinoma have reported complex karyotypes, with multiple numerical and/or structural abnormalities (Ochi et al, 1986; Ferti-Passantonopoulou et al, 1987; Seruca et al, 1993) . Loss of heterozygozity studies have identified a number of chromosomal regions that demonstrate allele loss in primary gastric tumours. These include chromosomes lq, 3p, 5q, 7q, lIp, 12q, 13q, 17p and 18q (Motomura et al, 1988; Sano et al, 1991; Uchino et al, 1992; Ranzani et al, 1993; Rhyu et al, 1994; Schneider et al, 1995) . In the majority of these studies, relatively few chromosomal arms have been examined and diverse patterns of allele loss have been reported by various groups. Differences in the environmental and genetic backgrounds of the various populations under study may contribute to variations in the pattern of genetic changes documented. However, these discrepancies may also reflect differences with respect to the site of origin (cardia vs antrum), histological subtype and stage of tumours analysed in a study.
The aim of the present study was to determine the pattern of allelic imbalance in a homogeneous series of proximal gastric adenocarcinomas, i.e. tumours arising in the gastric cardia. A total of 137 polymorphic markers covering all autosomal arms, excluding acrocentric arms, were examined. The relationship between clinicopathological parameters and allelic imbalance was assessed. A more detailed mapping was carried out on chromosomes 4q and 6q to identify chromosomal breakpoints delineating a minimum region of involvement in gastric tumorigenesis. (Hermanek and Sobin, 1987; Beahrs et al, 1988) .
MATERIALS AND METHODS

DNA extraction and microsatellite analysis
A total of 137 microsatellite markers covering all autosomal arms, excluding acrocentric arms, were analysed. DNA was extracted from matched control and tumour tissue samples and microsatellite analysis was carried out, as described previously (Gleeson et al, 1996) . As it was not possible to distinguish between chromosomal gains and chromosomal losses, the term allelic imbalance (AI), instead of loss of heterozygozity (LOH), was used to describe altered allelic ratios in tumour DNA. AI was assessed by direct visual comparison of the relative allelic ratios present in matched normal and tumour DNAs. To ensure that the allele intensities were within the linear range, multiple exposures of each autoradiograph were carried out. Autoradiographs were independently scored by CMG and SEHR. AT was scored if one allele was absent or exhibited altered signal intensity in tumour DNA relative to the allelic ratio of normal DNA. A small number of loci in this study demonstrated microsatellite instability (Gleeson et al, 1996 
RESULTS
The 38 gastric adenocarcinomas were histologically classified according to the procedure of Lauren (1965) . The samples included 29 cases of the intestinal type (well-differentiated (n = 6), moderately differentiated (n = 12), poorly differentiated (n = 11)) Representative autoradiographs demonstrating AI at various loci are shown in Figure 1 . Apparent total loss of one allele was evident at a number of loci, however Al was frequently observed. In these cases an altered ratio of allele signal intensity was observed in the tumour DNA relative to matched control DNA. The residual allele in the tumour sample may reflect the presence of contaminating stromal cells in the tumour tissue or alternatively a subpopulation of tumour cells may have retained both alleles. Allelic imbalance may also represent the amplification of a mutant allele without concomitant loss of the wild-type allele. Furthermore, cytogenetic and flow cytometric studies have indicated that gains in chromosome copy number occur frequently in gastric adenocarcinoma (Ochi et al, 1986; Ferti-Passantonopoulou et al, 1987; Flejou et al, 1994) . Polymorphic DNA markers will British Journal of Cancer (1997) 76(11), 1455-1465 Compared with histological subtype, a higher incidence of Al was detected on 16q in tumours of the diffuse type relative to those of the intestinal type (7 out of 9 vs 7 out of 26; P = 0.02, Fisher's exact test). A similar trend was observed when poorly differentiated diffuse-type tumours were compared directly with poorly differentiated intestinal-type tumours, but failed to reach statistical significance (7 out of 9 vs 3 out of 11; P = 0.07, Fisher's exact test). Within the intestinal-type tumour group, a number of loci demonstrated a trend towards weak association with the degree of tumour differentiation. Allelic imbalance on 3q was more commonly associated with poorly differentiated tumours relative to well-differentiated ones (7 out of 11 vs 0 out of 6; P = 0.03, Fisher's exact test). A similar trend was evident when well-moderately differentiated tumours were analysed as a group, but failed to reach statistical significance (4 out of 17 vs 7 out of 11; P = 0.08, Fisher's exact test). There was a trend towards increasing AI on lOp and lip in adenocarcinomas of the moderately differentiated subtype compared with those of the welldifferentiated subtype (lOp, 7 out of 11 vs 0 out of 5; 1ip, 7 out of 9 vs 1 out of 6; both P < 0.07, Fisher's exact test) and the poorly differentiated subtype (lOp, 7 out of 11 vs 1 out of 8; 1ip, 7 out of 9 vs 3 out of 11; both P < 0.075, Fisher's exact test). There was no association between AT at a specific chromosomal locus and tumour stage.
To map common regions of involvement on chromosomes 4q and 6q, additional microsatellite markers were analysed on these chromosomes. A number of cases were identified that showed clear evidence of chromosomal breakpoints. Six cases with breakpoints on 4q give preliminary evidence for the involvement of two distinct regions of 4q in gastric tumorigenesis. One region spans an approximate 14 cM interval delineated by retention of heterozygozity at D4S2361 (no. 44) and D4S 1647 (no. 37). There is evidence of involvement of a second locus on 4q. Retention of heterozygozity at markers D4S1090 (no. 68) and D4S1652 (no. 98) delineate a maximal 50 cM region of involvement. These data are represented diagrammatically in Figure 3A . Five cases were identified that showed evidence of breakpoints on chromosome 6q. The retention of heterozygozity at D6S 1003 (case no. 21) and D6S255 (no. 101) defines a 16-cM interval commonly involved in gastric tumorigenesis ( Figure 3B ). Examples of Al and retention of heterozygozity at the chromosomal breakpoints are shown in Figure 4 . DISCUSSION To identify chromosomal regions implicated in the development of proximal gastric carcinoma, this study presents the results of an allelotype analysis carried out on a series of 38 adenocarcinomas arising in the gastric cardia. The tumour group studied demonstrated a high level of AI for both the intestinal (median FAI = 0.47) and the diffuse (median FAI = 0.54) histological subtypes. These values are higher than those reported in previous studies of gastric carcinoma (Motomura et al, 1988; Wada et al, 1988) . This difference may be attributable to a number of factors. First, the tumours in this study consisted only of advanced-stage tumours (stage II or III) with no early-stage tumours (stage 0 or I). Previous studies of ovarian carcinoma have also reported high FAL values in two series of predominantly advanced carcinomas (Cliby et al, 1993) . Second, multiple markers were evaluated on most chromosomal arms and on average 35, out of a total of 39, chromosomal arms were informative for each patient. Third, the selection of tumour-rich regions for molecular analysis, may have facilitated a more reliable detection of AT than the study of DNA from unfractionated tumours, a factor that may have contributed to the detection of lower rates of allele loss in some studies (Wada et al, 1988 (Flejou et al, 1994) . (Neuman et al, 1991; Sano et al, 1991; McKie et al, 1993; Ranzani et al, 1993; Rhyu et al, 1994) . However, loss of the APC/MCC gene loci on 5q was documented in over 80% of flow-sorted, aneuploid cell populations in gastric carcinoma, suggesting that Sq LOH may be associated with the development of aneuploidy in these tumours (Tamura et al, 1993) . Inactivation of the APC gene, on 5q21, has been implicated in gastric tumorigenesis by the detection of mutations in 7-21% of tumours Nakatsura et al, 1992) . The detection of APC gene mutations in gastric adenomas [20% (6 out of 30)] indicates that such mutations may occur early in gastric tumour development (Tamura et al, 1994) . Deletion mapping on Sq in well-differentiated gastric adenocarcinoma identified two minimum regions of deletion, both of which were distinct from the APC gene locus (Tamura et al, 1996) . These data suggest a role for two additional putative tumour-suppressor genes on Sq in gastric carcinoma.
Microsatellite analysis detected AI on 13q in 53% (20 out of 38) of gastric adenocarcinomas. Motomura et al (1988) , reported allelic loss at 13q in 41% (14 out of 34) of gastric adenocarcinomas. However, other studies documented a lower incidence of 13q allelic loss, ranging from 19% to 30% of cases (Uchino et al, 1992; Ranzani et al, 1993; Schneider et al, 1995) . The involvement of Rb gene abnormalities in gastric carcinoma has not been reported.
British Journal of Cancer (1997) 76(11), [1455] [1456] [1457] [1458] [1459] [1460] [1461] [1462] [1463] [1464] [1465] In this study, the majority of gastric tumours displayed Al at either 17p or 18q or at both loci, suggesting that they are commonly involved in adenocarcinoma of the gastric cardia. Approximately 37.5-74% of gastric carcinomas were reported to demonstrate 17p allelic loss (Sano et al, 1991; Seruca et al, 1992; Ranzani et al, 1993; Rhyu et al, 1994; Schneider et al, 1995) . Both p53 gene mutation Uchino et al, 1993; Hongyo et al, 1995) and diffuse p53 protein expression (Flejou et al, 1994; Fukunaga et al, 1994) have been documented in gastric tumours, suggesting that p53 gene inactivation is the target of 17p allelic loss in these tumours. Schneider et al (1995) reported low levels of Al at the DCC-linked locus, D18S51 in gastric adenocarcinoma. Other studies, however, have reported levels of 18q LOH ranging from 47% to 61% of tumours, occurring in both early tumours and advanced tumours (Uchino et al, 1992; Ranzani et al, 1993) . A putative common region of deletion, including the DCC gene locus, has been identified at 18q21.3-qter (Uchino et al, 1992) .
Therefore, the present study and numerous previous reports have implicated allelic loss at Sq, 13q, 17p and 18q in gastric tumorigenesis. These chromosomes harbour the known tumoursuppressor genes APC/MCC, Rb, p53 and DCC (McBride et al, 1986; Lee et al, 1987; Fearon et al, 1990; Kinzler et al, 1991) . In addition to these loci, allelic loss has been documented on other chromosomal arms in gastric adenocarcinoma. (1993) demonstrated frequent LOH at Ilp (37%) in gastric adenocarcinoma. Subsequent deletion mapping confirmed a minimum region of deletion at llpl5.5 and also identified a second region of deletion at I1 q22-q23 (Baffa et al, 1996) . The detection of frequent LOH at lIpiS is consistent with a cytogenetic study detailing Ilpl3-15 rearrangements in seven out of eight cases of primary adenocarcinoma of the oesophagus and gastric cardia (Rodriguez et al, 1990) . In contrast to these observations, other cytogenetic studies failed to detect lIp rearrangements in gastric carcinoma (Ochi et al, 1986; Seruca et al, 1993) (Sano et al, 1991; Uchino et al, 1992 (Becker et al, 1994) . In contrast, intestinal-type carcinomas demonstrated silent mutations in 2 out of 20 tumours, indicating that E-cadherin gene mutations may contribute to the development of diffusely growing gastric carcinomas (Becker et al, 1994 Additional studies have suggested that allele loss at a number of loci may be specific to the development of particular subtypes of gastric carcinoma (Sano et al, 1991) . One study found evidence to suggest that LOH at lq, 5q and 7p may be associated with welldifferentiated adenocarcinoma, with LOH on lq and 7p being associated with tumour progression to advanced carcinoma. LOH on these chromosomes was not detected in poorly differentiated adenocarcinoma, including both intestinal and diffuse types (Sano et al, 1991) . LOH on 7q was not detected in early tumours, but was evident in advanced tumours of both well-and poorly differentiated subtypes, suggesting an association with tumour progression (Sano et al, 1991; Kuniyasu et al, 1994) .
Although Sano et al (1991) (Nakatsura et al, 1992) , but were also reported in undifferentiated and diffuse-type carcinomas, mainly of the signet-ring cell type Nakatsura et al, 1992 (Sano et al, 1991) or no associations (Schneider et al, 1995) (Allum et al, 1989) , and that the relatively low incidence of gastric carcinoma in Western countries hampers the acquisition of large tumour series for genetic analysis.
The sites of AI on 4q and 6q were examined in more detail and a subset of tumours was identified that exhibited clear evidence of chromosomal breakpoints. Cytogenetic studies have reported rearrangements involving 4q in both primary (Rodriguez et al, 1990) and metastatic (Cagle et al, 1989 ) gastric carcinoma.
Despite this, one allelotype study failed to detect frequent Al on 4q in gastric carcinoma (Schneider et al, 1995) . Allelic loss at 4q has been described relatively infrequently in human malignancies. Buetow et al (1989) reported LOH at the albumin gene locus (4q 1-12) in five out of five informative cases of hepatocellular carcinoma. This was confirmed in an independent study by the detection of allelic loss on 4q in 77% (23 out of 30) of hepatocellular carcinomas (Yeh et al, 1996) . Allelic loss on 4q has also been implicated in cervical carcinoma (Mitra et al, 1994) . The mapping of a senescence function to chromosome 4 provided evidence of a potential tumour-suppressor gene. Introduction of a normal chromosome 4 into three immortal cell lines, derived from a bladder carcinoma, a cervical carcinoma and a glioblastoma, was shown to result in loss of proliferation and reversal of the immortal phenotype (Ning et al, 1991) .
A number of cytogenetic studies have reported consistent abnormalities involving 6q21-6qter in gastric carcinoma (Ochi et al, 1986; Rodriguez et al, 1990; Seruca et al, 1993; Panani et al, 1995; Rao et al, 1995) , with one study documenting five tumours with a commonly deleted region spanning 6q21-6qter (Seruca et al, 1993) . A number of LOH studies failed to detect high levels of 6q allelic loss in gastric adenocarcinoma (Sano et al, 1991; Uchino et al, 1992) . More recently, deletion mapping on 6q in gastric carcinoma has identified two regions of deletion; one located between D6S268 (6ql6-q21) and ARGI (6q22-q23), and a second region distal to IFNGR1 (6q23-q24) (Queimado et al, 1995) . It will be of interest to determine if the minimum region identified in the present study, located between D6S1003 (6q23) and D6S255 (6q24-q25), corresponds to one of those identified in the other mapping study. Evidence in the literature suggests the presence of a number of tumour-suppressor genes on chromosome 6q.
Frequent 6q LOH has been described in a variety of tumour types, including breast (Orphanos et al, 1995) , ovarian (Cliby et al, 1993) and colorectal (Honchel et al, 1996) carcinoma. Microcell-mediated transfer of normal chromosome 6 was reported to result in reversion of the malignant phenotype in melanoma cell lines (Trent et al, 1990) . In agreement with the presence of a tumoursuppressor gene on 6q, loss of chromosomal loci distal to 6q21 was associated with the immortalization of SV40-transformed human diploid fibroblasts (Hubbard-Smith et al, 1992) .
In conclusion, this study documents the pattern of AI in a series of proximally located gastric adenocarcinomas. Gastric carcinoma is a heterogeneous disease, with proximal and distal gastric tumours displaying distinct biological and epidemiological features (Wang et al, 1986; Blot et al, 1991 
